ABIRISK · ABIRISK
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
Anti-Biopharmaceutical Immunization: Prediction and analysis of clinical relevance to minimize the risk of immunization in multiple sclerosis patients on interferon-beta treatment. ABI-MS-P01.
Sponsor: FUNDACIÓ VALL D'HEBRON
Phase: IV
Area: Neuroimmunology